The IGNITE network: A model for genomic medicine implementation and research

Kristin Wiisanen Weitzel, Madeline Alexander, Barbara A. Bernhardt, Neil Calman, David J. Carey, Larisa H. Cavallari, Julie R. Field, Diane Hauser, Heather A. Junkins, Phillip A. Levin, Kenneth Levy, Ebony B. Madden, Teri A. Manolio, Jacqueline Odgis, Lori A. Orlando, Reed Pyeritz, R. Ryanne Wu, Alan R. Shuldiner, Erwin P. Bottinger, Joshua C. DennyPaul Dexter, David A. Flockhart, Carol R. Horowitz, Julie A. Johnson, Stephen E. Kimmel, Mia A. Levy, Toni I. Pollin, Geoffrey S. Ginsburg

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Background: Patients, clinicians, researchers and payers are seeking to understand the value of using genomic information (as reflected by genotyping, sequencing, family history or other data) to inform clinical decision-making. However, challenges exist to widespread clinical implementation of genomic medicine, a prerequisite for developing evidence of its real-world utility. Methods: To address these challenges, the National Institutes of Health-funded IGNITE (Implementing GeNomics In pracTicE; www.ignite-genomics.org) Network, comprised of six projects and a coordinating center, was established in 2013 to support the development, investigation and dissemination of genomic medicine practice models that seamlessly integrate genomic data into the electronic health record and that deploy tools for point of care decision making. IGNITE site projects are aligned in their purpose of testing these models, but individual projects vary in scope and design, including exploring genetic markers for disease risk prediction and prevention, developing tools for using family history data, incorporating pharmacogenomic data into clinical care, refining disease diagnosis using sequence-based mutation discovery, and creating novel educational approaches. Results: This paper describes the IGNITE Network and member projects, including network structure, collaborative initiatives, clinical decision support strategies, methods for return of genomic test results, and educational initiatives for patients and providers. Clinical and outcomes data from individual sites and network-wide projects are anticipated to begin being published over the next few years. Conclusions: The IGNITE Network is an innovative series of projects and pilot demonstrations aiming to enhance translation of validated actionable genomic information into clinical settings and develop and use measures of outcome in response to genome-based clinical interventions using a pragmatic framework to provide early data and proofs of concept on the utility of these interventions. Through these efforts and collaboration with other stakeholders, IGNITE is poised to have a significant impact on the acceleration of genomic information into medical practice.

Original languageEnglish (US)
Article number1
JournalBMC Medical Genomics
Volume9
Issue number1
DOIs
StatePublished - Jan 5 2016

Fingerprint

Genomics
Point-of-Care Systems
Clinical Decision Support Systems
Medicine
Inborn Genetic Diseases
Electronic Health Records
Pharmacogenetics
National Institutes of Health (U.S.)
Genetic Markers
Research
Decision Making
Research Personnel
Outcome Assessment (Health Care)
Genome
Mutation
Clinical Decision-Making

Keywords

  • Clinical decision support
  • Electronic health record
  • Genomics
  • Implementation
  • Personalized medicine
  • Pharmacogenomics
  • Precision medicine

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Weitzel, K. W., Alexander, M., Bernhardt, B. A., Calman, N., Carey, D. J., Cavallari, L. H., ... Ginsburg, G. S. (2016). The IGNITE network: A model for genomic medicine implementation and research. BMC Medical Genomics, 9(1), [1]. https://doi.org/10.1186/s12920-015-0162-5

The IGNITE network : A model for genomic medicine implementation and research. / Weitzel, Kristin Wiisanen; Alexander, Madeline; Bernhardt, Barbara A.; Calman, Neil; Carey, David J.; Cavallari, Larisa H.; Field, Julie R.; Hauser, Diane; Junkins, Heather A.; Levin, Phillip A.; Levy, Kenneth; Madden, Ebony B.; Manolio, Teri A.; Odgis, Jacqueline; Orlando, Lori A.; Pyeritz, Reed; Wu, R. Ryanne; Shuldiner, Alan R.; Bottinger, Erwin P.; Denny, Joshua C.; Dexter, Paul; Flockhart, David A.; Horowitz, Carol R.; Johnson, Julie A.; Kimmel, Stephen E.; Levy, Mia A.; Pollin, Toni I.; Ginsburg, Geoffrey S.

In: BMC Medical Genomics, Vol. 9, No. 1, 1, 05.01.2016.

Research output: Contribution to journalArticle

Weitzel, KW, Alexander, M, Bernhardt, BA, Calman, N, Carey, DJ, Cavallari, LH, Field, JR, Hauser, D, Junkins, HA, Levin, PA, Levy, K, Madden, EB, Manolio, TA, Odgis, J, Orlando, LA, Pyeritz, R, Wu, RR, Shuldiner, AR, Bottinger, EP, Denny, JC, Dexter, P, Flockhart, DA, Horowitz, CR, Johnson, JA, Kimmel, SE, Levy, MA, Pollin, TI & Ginsburg, GS 2016, 'The IGNITE network: A model for genomic medicine implementation and research', BMC Medical Genomics, vol. 9, no. 1, 1. https://doi.org/10.1186/s12920-015-0162-5
Weitzel KW, Alexander M, Bernhardt BA, Calman N, Carey DJ, Cavallari LH et al. The IGNITE network: A model for genomic medicine implementation and research. BMC Medical Genomics. 2016 Jan 5;9(1). 1. https://doi.org/10.1186/s12920-015-0162-5
Weitzel, Kristin Wiisanen ; Alexander, Madeline ; Bernhardt, Barbara A. ; Calman, Neil ; Carey, David J. ; Cavallari, Larisa H. ; Field, Julie R. ; Hauser, Diane ; Junkins, Heather A. ; Levin, Phillip A. ; Levy, Kenneth ; Madden, Ebony B. ; Manolio, Teri A. ; Odgis, Jacqueline ; Orlando, Lori A. ; Pyeritz, Reed ; Wu, R. Ryanne ; Shuldiner, Alan R. ; Bottinger, Erwin P. ; Denny, Joshua C. ; Dexter, Paul ; Flockhart, David A. ; Horowitz, Carol R. ; Johnson, Julie A. ; Kimmel, Stephen E. ; Levy, Mia A. ; Pollin, Toni I. ; Ginsburg, Geoffrey S. / The IGNITE network : A model for genomic medicine implementation and research. In: BMC Medical Genomics. 2016 ; Vol. 9, No. 1.
@article{387255bdbbf24fd58808dcccb18bd825,
title = "The IGNITE network: A model for genomic medicine implementation and research",
abstract = "Background: Patients, clinicians, researchers and payers are seeking to understand the value of using genomic information (as reflected by genotyping, sequencing, family history or other data) to inform clinical decision-making. However, challenges exist to widespread clinical implementation of genomic medicine, a prerequisite for developing evidence of its real-world utility. Methods: To address these challenges, the National Institutes of Health-funded IGNITE (Implementing GeNomics In pracTicE; www.ignite-genomics.org) Network, comprised of six projects and a coordinating center, was established in 2013 to support the development, investigation and dissemination of genomic medicine practice models that seamlessly integrate genomic data into the electronic health record and that deploy tools for point of care decision making. IGNITE site projects are aligned in their purpose of testing these models, but individual projects vary in scope and design, including exploring genetic markers for disease risk prediction and prevention, developing tools for using family history data, incorporating pharmacogenomic data into clinical care, refining disease diagnosis using sequence-based mutation discovery, and creating novel educational approaches. Results: This paper describes the IGNITE Network and member projects, including network structure, collaborative initiatives, clinical decision support strategies, methods for return of genomic test results, and educational initiatives for patients and providers. Clinical and outcomes data from individual sites and network-wide projects are anticipated to begin being published over the next few years. Conclusions: The IGNITE Network is an innovative series of projects and pilot demonstrations aiming to enhance translation of validated actionable genomic information into clinical settings and develop and use measures of outcome in response to genome-based clinical interventions using a pragmatic framework to provide early data and proofs of concept on the utility of these interventions. Through these efforts and collaboration with other stakeholders, IGNITE is poised to have a significant impact on the acceleration of genomic information into medical practice.",
keywords = "Clinical decision support, Electronic health record, Genomics, Implementation, Personalized medicine, Pharmacogenomics, Precision medicine",
author = "Weitzel, {Kristin Wiisanen} and Madeline Alexander and Bernhardt, {Barbara A.} and Neil Calman and Carey, {David J.} and Cavallari, {Larisa H.} and Field, {Julie R.} and Diane Hauser and Junkins, {Heather A.} and Levin, {Phillip A.} and Kenneth Levy and Madden, {Ebony B.} and Manolio, {Teri A.} and Jacqueline Odgis and Orlando, {Lori A.} and Reed Pyeritz and Wu, {R. Ryanne} and Shuldiner, {Alan R.} and Bottinger, {Erwin P.} and Denny, {Joshua C.} and Paul Dexter and Flockhart, {David A.} and Horowitz, {Carol R.} and Johnson, {Julie A.} and Kimmel, {Stephen E.} and Levy, {Mia A.} and Pollin, {Toni I.} and Ginsburg, {Geoffrey S.}",
year = "2016",
month = "1",
day = "5",
doi = "10.1186/s12920-015-0162-5",
language = "English (US)",
volume = "9",
journal = "BMC Medical Genomics",
issn = "1755-8794",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The IGNITE network

T2 - A model for genomic medicine implementation and research

AU - Weitzel, Kristin Wiisanen

AU - Alexander, Madeline

AU - Bernhardt, Barbara A.

AU - Calman, Neil

AU - Carey, David J.

AU - Cavallari, Larisa H.

AU - Field, Julie R.

AU - Hauser, Diane

AU - Junkins, Heather A.

AU - Levin, Phillip A.

AU - Levy, Kenneth

AU - Madden, Ebony B.

AU - Manolio, Teri A.

AU - Odgis, Jacqueline

AU - Orlando, Lori A.

AU - Pyeritz, Reed

AU - Wu, R. Ryanne

AU - Shuldiner, Alan R.

AU - Bottinger, Erwin P.

AU - Denny, Joshua C.

AU - Dexter, Paul

AU - Flockhart, David A.

AU - Horowitz, Carol R.

AU - Johnson, Julie A.

AU - Kimmel, Stephen E.

AU - Levy, Mia A.

AU - Pollin, Toni I.

AU - Ginsburg, Geoffrey S.

PY - 2016/1/5

Y1 - 2016/1/5

N2 - Background: Patients, clinicians, researchers and payers are seeking to understand the value of using genomic information (as reflected by genotyping, sequencing, family history or other data) to inform clinical decision-making. However, challenges exist to widespread clinical implementation of genomic medicine, a prerequisite for developing evidence of its real-world utility. Methods: To address these challenges, the National Institutes of Health-funded IGNITE (Implementing GeNomics In pracTicE; www.ignite-genomics.org) Network, comprised of six projects and a coordinating center, was established in 2013 to support the development, investigation and dissemination of genomic medicine practice models that seamlessly integrate genomic data into the electronic health record and that deploy tools for point of care decision making. IGNITE site projects are aligned in their purpose of testing these models, but individual projects vary in scope and design, including exploring genetic markers for disease risk prediction and prevention, developing tools for using family history data, incorporating pharmacogenomic data into clinical care, refining disease diagnosis using sequence-based mutation discovery, and creating novel educational approaches. Results: This paper describes the IGNITE Network and member projects, including network structure, collaborative initiatives, clinical decision support strategies, methods for return of genomic test results, and educational initiatives for patients and providers. Clinical and outcomes data from individual sites and network-wide projects are anticipated to begin being published over the next few years. Conclusions: The IGNITE Network is an innovative series of projects and pilot demonstrations aiming to enhance translation of validated actionable genomic information into clinical settings and develop and use measures of outcome in response to genome-based clinical interventions using a pragmatic framework to provide early data and proofs of concept on the utility of these interventions. Through these efforts and collaboration with other stakeholders, IGNITE is poised to have a significant impact on the acceleration of genomic information into medical practice.

AB - Background: Patients, clinicians, researchers and payers are seeking to understand the value of using genomic information (as reflected by genotyping, sequencing, family history or other data) to inform clinical decision-making. However, challenges exist to widespread clinical implementation of genomic medicine, a prerequisite for developing evidence of its real-world utility. Methods: To address these challenges, the National Institutes of Health-funded IGNITE (Implementing GeNomics In pracTicE; www.ignite-genomics.org) Network, comprised of six projects and a coordinating center, was established in 2013 to support the development, investigation and dissemination of genomic medicine practice models that seamlessly integrate genomic data into the electronic health record and that deploy tools for point of care decision making. IGNITE site projects are aligned in their purpose of testing these models, but individual projects vary in scope and design, including exploring genetic markers for disease risk prediction and prevention, developing tools for using family history data, incorporating pharmacogenomic data into clinical care, refining disease diagnosis using sequence-based mutation discovery, and creating novel educational approaches. Results: This paper describes the IGNITE Network and member projects, including network structure, collaborative initiatives, clinical decision support strategies, methods for return of genomic test results, and educational initiatives for patients and providers. Clinical and outcomes data from individual sites and network-wide projects are anticipated to begin being published over the next few years. Conclusions: The IGNITE Network is an innovative series of projects and pilot demonstrations aiming to enhance translation of validated actionable genomic information into clinical settings and develop and use measures of outcome in response to genome-based clinical interventions using a pragmatic framework to provide early data and proofs of concept on the utility of these interventions. Through these efforts and collaboration with other stakeholders, IGNITE is poised to have a significant impact on the acceleration of genomic information into medical practice.

KW - Clinical decision support

KW - Electronic health record

KW - Genomics

KW - Implementation

KW - Personalized medicine

KW - Pharmacogenomics

KW - Precision medicine

UR - http://www.scopus.com/inward/record.url?scp=84952908541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952908541&partnerID=8YFLogxK

U2 - 10.1186/s12920-015-0162-5

DO - 10.1186/s12920-015-0162-5

M3 - Article

C2 - 26729011

AN - SCOPUS:84952908541

VL - 9

JO - BMC Medical Genomics

JF - BMC Medical Genomics

SN - 1755-8794

IS - 1

M1 - 1

ER -